Task: Answer the multiple-choice question.
Question: Which compound exhibits a -4.620% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) NC(=O)COC(=O)c1oc2ccccc2c1CSc1ccc(Cl)cc1
b.) O=C(COC(=O)c1cc(=O)[nH]c(=O)[nH]1)NCc1ccccc1
Answer: a. NC(=O)COC(=O)c1oc2ccccc2c1CSc1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NC(=O)COC(=O)c1oc2ccccc2c1CSc1ccc(Cl)cc1
NC(=O)COC(=O)c1oc2ccccc2c1CSc1ccc(Cl)cc1
(2-amino-2-oxoethyl) 3-[(4-chlorophenyl)sulfanylmethyl]-1-benzofuran-2-carboxylate